Filing Flows

Filing Flows › Comparisons › ETON vs AGIO

Eton Pharmaceuticals vs Agios Pharmaceuticals: ETON and AGIO compared

Eton Pharmaceuticals is the larger company: $57.9M of revenue in its latest quarter (Q3 2026) against $55.4M for Agios Pharmaceuticals (Q3 2026). Agios Pharmaceuticals is growing faster (+330% against +158% a year earlier). Eton Pharmaceuticals is more profitable, with an operating margin of 39.7% against -139.3%.

Eton Pharmaceuticals vs Agios Pharmaceuticals, latest quarterEton Pharmaceuticals vs Agios Pharmaceuticals, latest quarterEton Pharmaceuticals (ETON)Agios Pharmaceuticals (AGIO)Revenue$57.9M$55.4MRevenue growth, Y/Y+158%+330%Operating margin39.7%-139.3%Net margin60.9%-117.4%

Where the money goes: ETON and AGIO

Eton Pharmaceuticals (ETON) · Q3 2026

Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.

Agios Pharmaceuticals (AGIO) · Q3 2026

Agios Pharmaceuticals, Q3 2026: revenue $55.4M (+330% year over year), operating margin -139.3%, net loss $65.0M, operating cash flow −$59.2M. The chart follows the revenue to costs, profit and cash.

Eton Pharmaceuticals (ETON)Agios Pharmaceuticals (AGIO)
Latest quarterQ3 2026Q3 2026
Revenue$57.9M$55.4M
Revenue growth, Y/Y+158%+330%
Gross margin76.5%—
Operating margin39.7%-139.3%
Net earnings$35.2M−$65.0M
Net margin60.9%-117.4%
Operating cash flow$35.2M−$59.2M
Free cash flow$35.2M—
Market value—$1.9B
Analysts’ mean target—$45.88

Questions

Which is bigger, Eton Pharmaceuticals or Agios Pharmaceuticals?

Eton Pharmaceuticals is the larger company: $57.9M of revenue in its latest quarter (Q3 2026) against $55.4M for Agios Pharmaceuticals (Q3 2026).

Is Eton Pharmaceuticals or Agios Pharmaceuticals growing faster?

Agios Pharmaceuticals is growing faster (+330% against +158% a year earlier).

Which is more profitable, Eton Pharmaceuticals or Agios Pharmaceuticals?

Eton Pharmaceuticals is more profitable, with an operating margin of 39.7% against -139.3%.

More: Eton Pharmaceuticals earnings · how Eton Pharmaceuticals makes money · Agios Pharmaceuticals earnings · how Agios Pharmaceuticals makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.